Haplogen GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Haplogen GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11214
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Haplogen GmbH (Haplogen) is a biopharmaceutical company that improves human health by fighting against infectious diseases such as common cold, dengue fever, influenza and hepatitis C. The company utilizes its proprietary genetics technology platform to identify novel pathogen host factors and develops therapeutics for the treatment of infectious diseases. It undertakes the construction of next generation haploid genetics tools to support experimental human genetics and internal target discovery programs. Haplogen works in partnership with pharmaceutical and biotechnology companies to advance its drug discovery and development pipeline. The company collaborates with professional experts and partners. Haplogen is headquartered in Vienna, Austria.

Haplogen GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Haplogen GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Haplogen GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Haplogen GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Haplogen GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Haplogen GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Haplogen GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Cyclenium Pharma Enters into Research Agreement with Haplogen 10
Evotec Enters Into Agreement With Haplogen To Develop Drugs For Infectious Diseases 11
Licensing Agreements 12
Bayer Enters into Licensing Agreement with Haplogen and Evotec 12
Haplogen GmbH – Key Competitors 13
Haplogen GmbH – Key Employees 14
Haplogen GmbH – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Haplogen GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Haplogen GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Haplogen GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Haplogen GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Haplogen GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Haplogen GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cyclenium Pharma Enters into Research Agreement with Haplogen 10
Evotec Enters Into Agreement With Haplogen To Develop Drugs For Infectious Diseases 11
Bayer Enters into Licensing Agreement with Haplogen and Evotec 12
Haplogen GmbH, Key Competitors 13
Haplogen GmbH, Key Employees 14

List of Figures
Haplogen GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Haplogen GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Haplogen GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Haplogen GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Haplogen GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Haplogen GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Haplogen GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Haplogen GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Haplogen GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Scripps Health:企業の戦略的SWOT分析
    Scripps Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Royal Orchid Hotels Ltd
    Royal Orchid Hotels Ltd - Strategy, SWOT and Corporate Finance Report Summary Royal Orchid Hotels Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Golar LNG Ltd (GOL):石油・ガス:M&Aディール及び事業提携情報
    Summary Golar LNG Limited (Golar LNG) is a midstream liquefied natural gas (LNG) company. It provides liquefaction, transport, storage, and re-gasification services to customers in the LNG industry. The company owns and operates LNG carriers and FSRUs; and develops FLNGVs. Through a joint venture wi …
  • Censo Biotechnologies Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Censo Biotechnologies Ltd (Censo) formerly Roslin Cellab Limited, a subsidiary of Roslin Foundation, is a provider of human cells and contract research services for drug discovery, toxicity testing and cell banking. The company offers iPSC services; differentiated cell types; in vitro assays …
  • Siemens Healthcare GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Siemens Healthcare GmbH d/b/a Siemens Healthineers, a subsidiary of Siemens AG, is a global medical device company that designs, develops, manufactures and distributes medical devices and technologies for diagnostic markets. Its major products include healthcare IT and medical infrastructure …
  • Nine Dragons Paper (Holdings) Ltd
    Nine Dragons Paper (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report Summary Nine Dragons Paper (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Insightra Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Insightra Medical Inc (Insightra Medical), a subsidiary of GPB Life Science Holdings LLC is a medical device company that develops disposable devices. The company offers cardiovascular and surgical solutions. Its cardiovascular solutions include Ultra 7FR IAB and modulare. The Modulare Cathe …
  • Stiefel Laboratories Inc-製薬・医療分野:企業M&A・提携分析
    Summary Stiefel Laboratories Inc (Stiefel Laboratories), a subsidiary of GlaxoSmithKline Plc is a healthcare products provider that develops products for sun care, dry skin and clear skin. The company also offers research and development, manufacture, marketing and distribution of prescription medic …
  • Toll Holdings Ltd:企業の戦略的SWOT分析
    Toll Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • EDF Renewables Inc:企業の戦略的SWOT分析
    EDF Renewables Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • China Mobile Ltd (941):企業の財務・戦略的SWOT分析
    China Mobile Ltd (941) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Blue Cross and Blue Shield Association:企業の戦略的SWOT分析
    Blue Cross and Blue Shield Association - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Hopewell Holdings Ltd:企業の戦略的SWOT分析
    Hopewell Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Escher Group Holdings plc:企業の戦略・SWOT・財務情報
    Escher Group Holdings plc - Strategy, SWOT and Corporate Finance Report Summary Escher Group Holdings plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Kikkoman Corp:企業の戦略・SWOT・財務分析
    Kikkoman Corp - Strategy, SWOT and Corporate Finance Report Summary Kikkoman Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Maruho Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Maruho Co Ltd (Maruho) is a pharmaceutical company that carries out the research, development, production, and distribution of dermatological products. It product portfolio includes a wide range of prescription drugs, medical devices and other skincare products. The company also offers produ …
  • Keyence Corp (6861):企業の財務・戦略的SWOT分析
    Keyence Corp (6861) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • East Central Energy:企業の発電所・SWOT分析2018
    East Central Energy - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Itochu Corp (8001):石油・ガス:M&Aディール及び事業提携情報
    Summary Itochu Corp (Itochu) is a trading company. It offers domestic trading, import and export, and overseas trading. The company trades in products such as textile, machinery, metals, minerals, energy, chemicals, food, general products, information and communications technology, realty, insurance …
  • Parex Resources Inc (PXT):石油・ガス:M&Aディール及び事業提携情報
    Summary Parex Resources Inc (Parex) is an oil and gas exploration and development company that acquires, explores, develops and produces crude oil and natural gas in South America and the Caribbean. The company holds interests in land base of 1.7 million gross acres over 22 blocks in Colombia's Llan …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆